Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors

被引:6
|
作者
Cai, Yibo [1 ]
Liu, Zhuo [1 ]
Jiang, Lai [1 ]
Ma, Dening [1 ]
Zhou, Zhenyuan [1 ]
Ju, Haixing [1 ]
Zhu, Yuping [1 ]
机构
[1] Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp,Univ Chinese Acad Sci, Inst Basic Med & Canc IBMC,Dept Colerectal Surg, Hangzhou, Peoples R China
来源
关键词
gastroenteropancreatic neuroendocrine tumors; small tumor size; lymph node metastatic patterns; surgical strategy; SEER database; CONSENSUS GUIDELINES UPDATE; MANAGEMENT; CARCINOIDS; SURVIVAL; PROGNOSIS; NEOPLASMS; SURGERY; SIZE;
D O I
10.3389/fendo.2022.871830
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundRegional lymph node metastasis (LNM) is crucial for planning additional lymphadenectomy, and is directly correlated with poor prognosis in gastroenteropancreatic neuroendocrine tumors (GEP-NETs). However, the patterns of LNM for small (<= 20 mm) GEP-NETs remain unclear. This population-based study aimed at evaluating LNM patterns and identifying optimal surgical strategies from the standpoint of lymph node dissemination. MethodsThis retrospective cohort study retrieved data from the Surveillance, Epidemiology, and End Results (SEER) 18 registries database for 17,308 patients diagnosed as having localized well-differentiated GEP-NETs <= 20 mm between January 1, 2004, and December 31, 2017. The patterns of LNM were characterized in 6,622 patients who underwent extended resection for adequate lymph node harvest. ResultsOf 6,622 patients with localized small GEP-NETs in the current study, 2,380 (36%) presented with LNM after regional lymphadenectomy. Nodal involvement was observed in approximately 7.4%, 49.1%, 13.6%, 53.7%, 13.8%, 7.8%, and 15.4% of gastric (g-), small intestinal (si-), appendiceal (a-), colonic (c-), rectal (r-), non-functional pancreatic (nfp-), and functional pancreatic (fp-) NETs <= 20 mm. Patients with younger age, larger tumor size, and muscularis invasion were more likely to present with LNM. Additional lymphadenectomy conferred a significant survival advantage in NETs (<= 10 mm: HR, 0.47; 95% CI, 0.33-0.66; p < 0.001; 11-20 mm: HR, 0.54; 95% CI, 0.34-0.85; p = 0.008) and fp-NETs <= 20 mm (HR, 0.08; 95% CI, 0.02-0.36; p = 0.001), as well as g-NETs (HR, 0.39; 95% CI, 0.16-0.96; p = 0.041) and c-NETs of 11-20 mm (HR, 0.07; 95% CI, 0.01-0.48; p = 0.007). Survival benefits of additional lymphadenectomy were not found in a-NETs, r-NETs, and nfp-NETs with a small size. ConclusionsGiven the increased risk for nodal metastasis, primary tumor resection with regional lymphadenectomy is a potential optimal surgical strategy for si-NETs and fp-NETs <= 20 mm, as well as g-NETs and c-NETs of 11-20 mm. Local resection is an appropriate and reliable surgical approach for a-NETs, r-NETs, and nfp-NETs <= 20 mm.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Difficulty of predicting lymph node metastasis on CT in patients with rectal neuroendocrine tumors
    Ushigome, Hajime
    Fukunaga, Yosuke
    Nagasaki, Toshiya
    Akiyoshi, Takashi
    Konishi, Tsuyoshi
    Fujimoto, Yoshiya
    Nagayama, Satoshi
    Ueno, Masashi
    PLOS ONE, 2019, 14 (02):
  • [22] Analysis of the factors affecting lymph node metastasis and the prognosis of rectal neuroendocrine tumors
    Li, Peng
    Wu, Fan
    Zhao, Hong
    Dou, Lizhou
    Wang, Yang
    Guo, Chunguang
    Wang, Guiqi
    Zhao, Dongbing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (10): : 13331 - 13338
  • [23] Risk Factors of Lymph Node Metastasis in Patients with Pancreatic Neuroendocrine Tumors (PNETs)
    Wang, Zhe
    Cao, Feng
    Zhang, Yupeng
    Fang, Yu
    Li, Fei
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2020, 2020
  • [24] Risk Factors for Lymph Node Metastasis and Survival Outcomes in Colorectal Neuroendocrine Tumors
    Wu, Zijian
    Wang, Zhijie
    Zheng, Zhaoxu
    Bi, Jianjun
    Wang, Xishan
    Feng, Qiang
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 7151 - 7164
  • [25] Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics
    Mizumoto, Takuya
    Toyama, Hirochika
    Terai, Sachio
    Mukubou, Hideyo
    Yamashita, Hironori
    Shirakawa, Sachiyo
    Nanno, Yoshihide
    Sofue, Keitaro
    Kido, Masahiro
    Ajiki, Tetsuo
    Fukumoto, Takumi
    PANCREATOLOGY, 2017, 17 (06) : 956 - 961
  • [26] Heterogeneity of Small Intestinal Neuroendocrine Tumors Metastasis: Biologic Patterns of a Series with Virchow's Node Involvement
    Wedin, Maria
    Tsoli, Marina
    Wallin, Goeran
    Janson, Eva Tiensuu
    Koumarianou, Anna
    Kaltsas, Gregory
    Daskalakis, Kosmas
    CANCERS, 2022, 14 (04)
  • [27] Prognostic Significance of Lymph Node Metastases in Small Intestinal Neuroendocrine Tumors
    Kim, Michelle Kang
    Warner, Richard R. P.
    Ward, Stephen C.
    Harpaz, Noam
    Roayaie, Sasan
    Schwartz, Myron E.
    Itzkowitz, Steven
    Wisnivesky, Juan
    NEUROENDOCRINOLOGY, 2015, 101 (01) : 58 - 65
  • [28] A Validated Risk-Score Model to Predict Lymph Node Metastases in Patients with Gastroenteropancreatic Neuroendocrine Tumors
    Shannon, Adrienne B.
    Straker, Richard J., III
    Fraker, Douglas L.
    Miura, John T.
    Karakousis, Giorgos C.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 233 (05) : S242 - S242
  • [29] Ki-67 Index as a Guide to Surgical Management of Small Pancreatic Neuroendocrine Neoplasms for Lymph Node Metastasis
    Masui, T.
    Anazawa, T.
    Nagai, K.
    Uchida, Y.
    Nakano, K.
    Takaori, K.
    Uemoto, S.
    NEUROENDOCRINOLOGY, 2019, 108 : 247 - 247
  • [30] Lymph Node Size on Computed Tomography Images Is a Predictive Indicator for Lymph Node Metastasis in Patients with Colorectal Neuroendocrine Tumors
    Tanaka, Toshiaki
    Nozawa, Hiroaki
    Kawai, Kazushige
    Hata, Keisuke
    Kiyomatsu, Tomomichi
    Nishikawa, Takeshi
    Otani, Kensuke
    Sasaki, Kazuhito
    Murono, Koji
    Watanabe, Toshiaki
    IN VIVO, 2017, 31 (05): : 1011 - 1017